130 related articles for article (PubMed ID: 2979108)
1. Absence of prostaglandin changes associated with protamine administration in patients with pulmonary hypertension.
Konstadt SN; Thys DM; Kong D; Mindich BP; Watkins WD
J Cardiothorac Anesth; 1987 Oct; 1(5):388-91. PubMed ID: 2979108
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane mediates acute pulmonary hypertension in sheep extracorporeal perfusion.
Peterson MB; Huttemeier PC; Zapol WM; Martin EG; Watkins WD
Am J Physiol; 1982 Sep; 243(3):H471-9. PubMed ID: 7051860
[TBL] [Abstract][Full Text] [Related]
4. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
Schumacher WA; Heran CL; Ogletree ML
Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans.
Faymonville ME; Deby-Dupont G; Larbuisson R; Deby C; Bodson L; Limet R; Lamy M
J Thorac Cardiovasc Surg; 1986 Jun; 91(6):858-66. PubMed ID: 3520158
[TBL] [Abstract][Full Text] [Related]
6. Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions.
Montalescot G; Kreil E; Lynch K; Greene EM; Torres A; Carvalho A; Fitzgibbon C; Robinson DR; Lowenstein E; Zapol WM
J Appl Physiol (1985); 1989 May; 66(5):2344-50. PubMed ID: 2745299
[TBL] [Abstract][Full Text] [Related]
7. Heparin-enhanced plasma phospholipase A2 activity and prostacyclin synthesis in patients undergoing cardiac surgery.
Nakamura H; Kim DK; Philbin DM; Peterson MB; Debros F; Koski G; Bonventre JV
J Clin Invest; 1995 Mar; 95(3):1062-70. PubMed ID: 7883954
[TBL] [Abstract][Full Text] [Related]
8. Effects of a thromboxane receptor antagonist (NT-126) and a thromboxane synthase inhibitor (OKY-O46) on protamine-induced circulatory changes in dogs.
Mizutani T; Takahashi S; Kihara S; Toyooka H
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):687-92. PubMed ID: 11139110
[TBL] [Abstract][Full Text] [Related]
9. Effect of leukopenia on pulmonary hypertension after heparin-protamine in pigs.
Habazettl H; Conzen PF; Vollmar B; Yekebas E; Peter K
J Appl Physiol (1985); 1992 Jul; 73(1):44-9. PubMed ID: 1506397
[TBL] [Abstract][Full Text] [Related]
10. Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation.
Morel DR; Lowenstein E; Nguyenduy T; Robinson DR; Repine JE; Chenoweth DE; Zapol WM
Circ Res; 1988 May; 62(5):905-15. PubMed ID: 3129208
[TBL] [Abstract][Full Text] [Related]
11. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb.
Kurrek MM; Winkler M; Robinson DR; Zapol WM
Anesthesiology; 1995 Jan; 82(1):183-7; discussion 31A. PubMed ID: 7832299
[TBL] [Abstract][Full Text] [Related]
12. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
Morel DR; Costabella PM; Pittet JF
Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
[TBL] [Abstract][Full Text] [Related]
13. Correlation between umbilical artery resistance index, 6 ketoprostaglandin F1 alpha and thromboxane B2 in the fetoplacental compartment in patients with pregnancy induced hypertension.
Mahmoud TZ; Bjornsson S; Kelly RW; Calder AA
Prostaglandins; 1993 Jun; 45(6):509-15. PubMed ID: 8337411
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 mediates hemodynamic and respiratory dysfunction in graded bacteremia.
Slotman GJ; Yellin SA; Handy JR; Hulstyn M; Husain SE; Gann DS
Surgery; 1986 Aug; 100(2):214-21. PubMed ID: 3526603
[TBL] [Abstract][Full Text] [Related]
15. Imaging the ovine heparin-protamine interaction with 111In-protamine.
Montalescot G; Fischman AJ; Strauss HW; Wilkinson RA; Ahmad M; Fitzgibbon C; Robinson DW; Zapol WM
J Appl Physiol (1985); 1993 Aug; 75(2):963-71. PubMed ID: 8226502
[TBL] [Abstract][Full Text] [Related]
16. Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension.
Ichida F; Uese K; Hamamichi Y; Hashimoto I; Tsubata S; Fukahara K; Murakami A; Miyawaki T
Acta Paediatr Jpn; 1998 Feb; 40(1):14-9. PubMed ID: 9583194
[TBL] [Abstract][Full Text] [Related]
17. Heparin-protamine reactions in pigs: role of oxygen-derived free radicals.
Vollmar B; Conzen PF; Habazettl H; Yekebas E; Peter K
J Appl Physiol (1985); 1993 May; 74(5):2412-20. PubMed ID: 8335575
[TBL] [Abstract][Full Text] [Related]
18. The role of neural and vasoactive mediators in the regulation of the pulmonary circulation during cardiopulmonary preservation.
Mashburn JP; Kontos GJ; Hashimoto K; Wilson DM; Schaff HV
J Thorac Cardiovasc Surg; 1989 Sep; 98(3):434-42; discussion 442-3. PubMed ID: 2770325
[TBL] [Abstract][Full Text] [Related]
19. Comparison of thromboxane synthetase inhibitor and methylprednisolone effects on protamine responses in dogs.
Fomsgaard JS; Kim YD; Burke TA; Viswanathan T; Schaffer AV; Peppard J; Douglas FL; Danchak M; Myers AK
Anesth Analg; 1992 Jan; 74(1):38-43. PubMed ID: 1734796
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep.
Fratacci MD; Frostell CG; Chen TY; Wain JC; Robinson DR; Zapol WM
Anesthesiology; 1991 Dec; 75(6):990-9. PubMed ID: 1741521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
